Torrent pharma- tracking the reaccumualtion

Torrent pharma filed 13 ANDAs in FY18 [us market],currently 46 ANDAs are pending for approval including six from Biopharma.,Overall it has 51 filings pending with US FDA including 5 tentative approvals,plans to file 15-20 ANDAs in the US in FY19 and expects eight to 10 approvals. Launched Hydrocodonsuppository from Biopharma portfolio in 4QFY18, To launch 8-9 products in FY19, Spent Rs 4.6bn in R&D in FY18, Unichem domestic portfolio has started growing post acquisition, Brazil was flat due to higher base and disturbances, single digit [5-6%]growth in Brazil in FY19 expected, To see strong growth in Germany in FY19,launched 17 products in Germany in FY18 and plans to launch 16 more in FY19, Expect 27% effective tax rate in FY19, Capex guidance at Rs 2bn for FY19 (maintenance capex mainly, believes most of the fresh capex has been done in FY18).
The chronic: acute ratio for the domestic formulations is 3:1…
Management expects significant synergies from the acquisition and have guided for the Unichem portfolio to exceed market growth rate in the near to medium term.

THE next phase of growth is due to start...

the MAcD has a bearish divergence and a bearish cross over impending with the signal
there might be a small correction to retest the 52week wilder moving average...
Entry planned there...
syot kilat
I guess in the current calender year the stock should be volatile, thus , a systematic entry is a good option, better if chart based entry is taken...
for me, i will do both lumpsome and systematic entry... the idea buy order would be 1267, but i doubt if that level would be tested or not... but on the next upmov on volumes if the creek region again produces resistance then there might be another late shakeout attempted... then the desired level might come up.. also on this drop i am expecting lower 1300 to come up where i will be a buyer...
the another lumpsome entry spot for me would be once the creek resistance is broken up on volumes ...

Although the target has been mentioned as a provisional one, i will revise it as time comes...

THe scrip has completed 5 waves up ... and is now in a complex correction speaking of waves... a wave 2 correction of the supercycle is going on the end of which is suspected to be quite near .. maybe end of next year? Then starts the wave 3 of the supercycle..
I would definitely want to be a part of that..
Valuation wise the scrip was never dirt cheap, and i dont expect it to be too..
Good things are never available cheap unless misspriced by Mr.Market.! this one is not...

If i am betting for a phoenix move form the pharma space in fy2020 onwards, torrent pharma would be a preference besides Sun pharma...
Disclaimer.. not invested, tracking fundamentals....
Not an investing/trading recommendation...

NB: i will be updating the fundamentals along with technicals in the below section, which are a part of my notes about the company...


Trend Analysis

Penafian